• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin Microbiol Infect . Seroprevalence of SARS-CoV-2 immunoglobulin antibodies in Wuhan, China: part of the city-wide massive testing campaign

tetano

Editor, Senior Moderator
Clin Microbiol Infect


. 2020 Oct 6;S1198-743X(20)30598-X.
doi: 10.1016/j.cmi.2020.09.044. Online ahead of print.
Seroprevalence of SARS-CoV-2 immunoglobulin antibodies in Wuhan, China: part of the city-wide massive testing campaign


Yunbao Pan[SUP] 1 [/SUP], Xinran Li[SUP] 1 [/SUP], Gui Yang[SUP] 1 [/SUP], Junli Fan[SUP] 1 [/SUP], Yueting Tang[SUP] 1 [/SUP], Xiaoyue Hong[SUP] 1 [/SUP], Shuang Guo[SUP] 1 [/SUP], Jin Li[SUP] 1 [/SUP], Dongai Yao[SUP] 2 [/SUP], Zhenshun Cheng[SUP] 3 [/SUP], Yufeng Yuan[SUP] 4 [/SUP], Yirong Li[SUP] 5 [/SUP], Xinghuan Wang[SUP] 6 [/SUP]



Affiliations
Free PMC article

Abstract

Objectives: The outbreak of 2019 coronavirus disease (COVID-19) pandemic in Wuhan, China, has subsided after a hard hit by the disease and subsequent city lockdown. Information on the number of people involved in Wuhan is still inadequate. This study aimed to describe the screening results of 61,437 community members in Wuchang District, Wuhan.
Methods: In mid-May 2020, Wuhan launched a population-scale city-wide SARS-CoV-2 testing campaign, which aimed to perform nucleic acid and viral antibody testing for citizens in Wuhan. Here we show the screening results of cluster sampled 61,437 residents in Wuchang District, Wuhan, China.
Results: A total of 1470 (2.39%, 95% CI: 2.27-2.52) individuals were detected positive for at least one antiviral antibody. Among the positive individuals, 324 (0.53%, 95% CI: 0.47-0.59) and 1200 (1.95%, 95% CI: 1.85-2.07) were positive for immunoglobulin IgM and IgG, respectively, and 54 (0.08%, 95% CI: 0.07-0.12) were positive for both antibodies. The positive rate of female carriers of antibodies were higher than those of male counterparts (male-to-female ratio of 0.75), especially in elderly citizens (ratio of 0.18 in 90+ age subgroup), indicating a sexual discrepancy in seroprevalence. In addition, viral nucleic acid detection using real-time PCR had showed 8 (0.013%, 95% CI: 0.006-0.026) asymptomatic virus carriers.
Conclusions: The seroprevalence of SARS-CoV-2 in Wuhan was low. Most of Wuhan residents are still susceptible to this virus. Precautions, such as wearing mask, frequent hand hygiene, and proper social distance, are necessary before an effective vaccine or antiviral treatments are available.

Keywords: 2019 novel Coronavirus; COVID-19; SARS-CoV-2; colloidal gold-based immunochromatographic strip; immunoglobulin antibody.
 
Back
Top Bottom